{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:06:27Z","timestamp":1784649987793,"version":"3.55.0"},"reference-count":228,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2026NSFSC1914"],"award-info":[{"award-number":["2026NSFSC1914"]}]},{"name":"National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University","award":["Z2023JC002"],"award-info":[{"award-number":["Z2023JC002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Neoadjuvant immunochemotherapy (NICT), mainly anti-PD-1\/PD-L1 therapy combined with cytotoxic chemotherapy, significantly improved perioperative outcomes for resectable solid tumors such as lung cancer and breast cancer. But a large number of patients still had residual lesions and eventually relapsed. Residual tumor cells are not simply unremoved cellular debris, but represent a therapy-selected and therapy-amplified subset of a pre-existing heterogeneous and plastic tumor ecosystem. To avoid implying that therapy generates a new form of tumor plasticity de novo, we use the term \u201cplasticity of non-apoptotic residual tumor cells\u201d to describe the plastic behavior of viable malignant cells that survive treatment-induced cytotoxicity rather than entering apoptosis. In this review, we define the plasticity of non-apoptotic residual tumor cells as the capacity of residual malignant cells to preserve, switch, or re-enter phenotypic states such as dormancy, hybrid EMT, stem-like regeneration, and immune evasion under the combined influence of intrinsic tumor heterogeneity, systemic therapy pressure, and microenvironmental protection. Before the NICT-specific discussion, we outline general theoretical frameworks including therapeutic stress response, apoptosis-induced regeneration, genetic and non-genetic heterogeneity, as well as spatial heterogeneity of involved lymph nodes, so as to provide a more robust interpretation of residual lesion biology under NICT. Also, this review proposes that residual disease may be reconceptualized as a treatment-shaped plastic niche, whose biological behavior is jointly shaped by clonal selection, reversible phenotypic transformation, and microenvironmental ecological protection. We summarize several key states of residual tumor cells: persistent-like\/resting state, hybrid EMT\/invasive plasticity state, stem-like\/regenerative state, and immune escape state, and elucidate the underlying epigenetic basis, including DNA methylation, histone modification, chromatin remodeling, and non-coding RNA network reprogramming. Meanwhile, niche factors such as immune stress, CAF\/TAM enrichment, fibrotic matrix, hypoxia, and metabolic stress can further stabilize these states and promote the survival of relapse seeds. Based on this, we propose that future postoperative assessments should be upgraded from residual volume to a stratified residual state, and dynamically identified by combining single-cell omics, spatial pathology, and ctDNA\/MRD monitoring. Furthermore, treatment strategies should shift from simply shrinking tumors to plasticity-locking therapy, that is, identifying, classifying, and blocking the plasticity escape pathways of residual lesions before they evolve into recurrence.<\/jats:p>","DOI":"10.3390\/biom16071065","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:17:52Z","timestamp":1784647072000},"page":"1065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasticity of Non-Apoptotic Residual Tumor Cells After Neoadjuvant Immunochemotherapy: Epigenetic and Microenvironmental Determinants"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-8720","authenticated-orcid":false,"given":"Wenjun","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Pain Management, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyue","family":"Li","sequence":"additional","affiliation":[{"name":"Outpatient Department, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiliang","family":"Xie","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangyi","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Pain Management, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-0390","authenticated-orcid":false,"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Department of Biotherapy, Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11864-024-01184-6","article-title":"Preoperative Strategies for Locally Advanced Colon Cancer","volume":"25","author":"Nair","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1541-7786.MCR-21-0038","article-title":"Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer","volume":"20","author":"Leonce","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yehan, Z., Sheng, Q., Hong, Y., Jiayu, L., Jun, H., Juan, J., Min, S., Jiaxin, Y., Shangzhi, H., and Yi, W. (2024). To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1312380"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.21037\/jtd-24-828","article-title":"Tumor immune microenvironment remodeling and prognosis of patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy with and without immunotherapy: A retrospective cohort study","volume":"16","author":"Liu","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhai, W., Zhang, C., Duan, F., Xie, J., Dai, S., Lin, Y., Yan, Q., Rao, B., Li, L., and Zhou, Y. (2024). Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: A multi-cohort retrospective study. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1422717"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Larios, F., Gonzalez, M.R., Ruiz-Arellanos, K., Aquilino, E.S.G., and Pretell-Mazzini, J. (2024). Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?\u2014A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16020443"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s43018-025-00990-7","article-title":"The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types","volume":"6","author":"Awada","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"eaax0182","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2215530","article-title":"Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer","volume":"389","author":"Provencio","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative Nivolumab in Resectable Lung Cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13643-025-02767-6","article-title":"Perioperative or neo\/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: A systematic review and network meta-analysis","volume":"14","author":"Zhang","year":"2025","journal-title":"Syst. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: Tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ccell.2026.02.008","article-title":"Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer","volume":"44","author":"Campisi","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1038\/cddis.2013.250","article-title":"Paracrine control of tissue regeneration and cell proliferation by Caspase-3","volume":"4","author":"Boland","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"118245","DOI":"10.1016\/j.biopha.2025.118245","article-title":"Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates","volume":"189","author":"Lim","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_22","first-page":"14176","article-title":"Multimodal immune activation abilities and characteristics of reovirus","volume":"13","author":"Kim","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: A link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tuomela, K., Ambrose, A.R., and Davis, D.M. (2022). Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.867098"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccell.2026.01.015","article-title":"Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer","volume":"44","author":"Zhao","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"112078","DOI":"10.1016\/j.intimp.2024.112078","article-title":"Association of pathological response with long-term survival outcomes after neoadjuvant immunotherapy: A meta-analysis","volume":"133","author":"Wei","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sacco, J.L., and Gomez, E.W. (2024). Epithelial-Mesenchymal Plasticity and Epigenetic Heterogeneity in Cancer. Cancers, 16.","DOI":"10.3390\/cancers16193289"},{"key":"ref_28","first-page":"335","article-title":"Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies\u2014Do we know enough to overcome this?","volume":"23","author":"Sempowicz","year":"2024","journal-title":"EXCLI J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1002\/1878-0261.70030","article-title":"Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation","volume":"19","author":"Dadiani","year":"2025","journal-title":"Mol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jamaoncol.2024.3679","article-title":"Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer: A Review","volume":"10","author":"Tarantino","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-13-0286","article-title":"Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets","volume":"4","author":"Balko","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"eaax8313","DOI":"10.1126\/scitranslmed.aax8313","article-title":"Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype","volume":"12","author":"Lupo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"He, Y., Yang, D., Lin, X., Zhang, J., Cheng, R., Cao, L., Yang, L., Zhang, M., Shi, X., and Jin, X. (2024). Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and CD16+ NK cells. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1412693"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ramesh, R.P.G., Yasmin, H., Ponnachan, P., Al-Ramadi, B., Kishore, U., and Joseph, A.M. (2025). Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1573522"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Valcz, G., Buz\u00e1s, E.I., Sebesty\u00e9n, A., Kren\u00e1cs, T., Sz\u00e1ll\u00e1si, Z., Igaz, P., and Moln\u00e1r, B. (2020). Extracellular Vesicle-Based Communication May Contribute to the Co-Evolution of Cancer Stem Cells and Cancer-Associated Fibroblasts in Anti-Cancer Therapy. Cancers, 12.","DOI":"10.3390\/cancers12082324"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.7150\/thno.101393","article-title":"The LRP4\/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer","volume":"15","author":"Forissier","year":"2025","journal-title":"Theranostics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1038\/s41467-025-66376-6","article-title":"Drug-tolerant persister cells in cancer: Bridging the gaps between bench and bedside","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Krasovec, G., Horkan, H.R., Qu\u00e9innec, \u00c9., and Chambon, J.P. (2022). The constructive function of apoptosis: More than a dead-end job. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1033645"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature20785","article-title":"Early dissemination seeds metastasis in breast cancer","volume":"540","author":"Hosseini","year":"2016","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","article-title":"Quantitative evidence for early metastatic seeding in colorectal cancer","volume":"51","author":"Hu","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12935-025-03734-w","article-title":"Intratumoral heterogeneity and drug resistance in cancer","volume":"25","author":"Fu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41568-025-00814-x","article-title":"Evolutionary paths towards metastasis","volume":"25","author":"Naxerova","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.cllc.2020.02.027","article-title":"Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease","volume":"21","author":"Wang","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e230018","DOI":"10.1148\/rycan.230018","article-title":"Skip and Mediastinal Metastasis in Papillary Thyroid Cancer","volume":"5","author":"Guarnizo","year":"2023","journal-title":"Radiol. Imaging Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nm.2385","article-title":"Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy","volume":"17","author":"Huang","year":"2011","journal-title":"Nat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.2147\/OTT.S130131","article-title":"PD-1 blockade restores impaired function of ex vivo expanded CD8(+) T cells and enhances apoptosis in mismatch repair deficient EpCAM(+)PD-L1(+) cancer cells","volume":"10","author":"Kumar","year":"2017","journal-title":"Onco Targets Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/0008-5472.CAN-23-1067","article-title":"Lineage Plasticity: The New Cancer Hallmark on the Block","volume":"84","author":"Mehta","year":"2024","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101114","DOI":"10.1016\/j.drup.2024.101114","article-title":"Cancer plasticity in therapy resistance: Mechanisms and novel strategies","volume":"76","author":"Niu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","article-title":"Cellular Plasticity in Cancer","volume":"9","author":"Yuan","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"Blanpain","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","article-title":"Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance","volume":"24","author":"Gupta","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/0008-5472.CAN-25-0999","article-title":"Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm","volume":"85","author":"Oliveira","year":"2025","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Matuschek, C., Jazmati, D., B\u00f6lke, E., Tamaskovics, B., Corradini, S., Budach, W., Krug, D., Mohrmann, S., Ruckh\u00e4berle, E., and Fehm, T. (2022). Post-Neoadjuvant Treatment Strategies in Breast Cancer. Cancers, 14.","DOI":"10.3390\/cancers14051246"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-24-3726","article-title":"Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy","volume":"31","author":"Reike","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Lejeune, M., Revert\u00e9, L., Sauras, E., Gallardo, N., Bosch, R., Roso, A., Petit, A., Peg, V., Riu, F., and Garc\u00eda-Fontgivell, J. (2023). Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response. Cancers, 15.","DOI":"10.3390\/cancers15030597"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e003984","DOI":"10.1136\/jitc-2021-003984","article-title":"Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis","volume":"10","author":"Xing","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Meng, W., Huang, L., Guo, J., Xin, Q., Liu, J., and Hu, Y. (2024). Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121549"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1158\/0008-5472.CAN-24-3037","article-title":"Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts","volume":"85","author":"Flynn","year":"2025","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e70406","DOI":"10.1002\/ctm2.70406","article-title":"Cancer stem cells: Bridging microenvironmental interactions and clinical therapy","volume":"15","author":"Wang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","article-title":"MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC","volume":"640","author":"Fiorini","year":"2025","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","article-title":"Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment","volume":"54","author":"Barkley","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.cell.2024.04.032","article-title":"A developmental constraint model of cancer cell states and tumor heterogeneity","volume":"187","author":"Patel","year":"2024","journal-title":"Cell"},{"key":"ref_68","first-page":"1","article-title":"Drug-tolerant persister cancer cells","volume":"4","author":"Wang","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"107163","DOI":"10.1016\/j.phrs.2024.107163","article-title":"Pharmacological agents targeting drug-tolerant persister cells in cancer","volume":"203","author":"Chen","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s43018-024-00819-9","article-title":"Targeting therapy-persistent residual disease","volume":"5","author":"Sun","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"znae103","DOI":"10.1093\/bjs\/znae103","article-title":"Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma","volume":"111","author":"Walker","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/CCO.0000000000001013","article-title":"Unveiling the role of cellular dormancy in cancer progression and recurrence","volume":"36","author":"Collignon","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST20230426","article-title":"Bivalent chromatin: A developmental balancing act tipped in cancer","volume":"52","author":"Glancy","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Rinke, J., Chase, A., Cross, N.C.P., Hochhaus, A., and Ernst, T. (2020). EZH2 in Myeloid Malignancies. Cells, 9.","DOI":"10.3390\/cells9071639"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/2159-8290.CD-23-1161","article-title":"Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells","volume":"14","author":"Rosano","year":"2024","journal-title":"Cancer Discov."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"lnae040","DOI":"10.1093\/lifemedi\/lnae040","article-title":"Metabolic orchestration of drug-tolerant persister cells in cancer","volume":"3","author":"Nie","year":"2024","journal-title":"Life Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chen, H.L., and Jin, W.L. (2024). Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth. Medicina, 60.","DOI":"10.3390\/medicina60020228"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1038\/s41467-024-47423-0","article-title":"Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer","volume":"15","author":"Haderk","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41388-023-02749-9","article-title":"Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer","volume":"42","author":"Sample","year":"2023","journal-title":"Oncogene"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","article-title":"The epithelial-mesenchymal plasticity landscape: Principles of design and mechanisms of regulation","volume":"24","author":"Haerinck","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semcancer.2012.05.003","article-title":"The epithelial-mesenchymal transition under control: Global programs to regulate epithelial plasticity","volume":"22","author":"Nieto","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Hong, T., Watanabe, K., Ta, C.H., Villarreal-Ponce, A., Nie, Q., and Dai, X. (2015). An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004569"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Jolly, M.K., Boareto, M., Huang, B., Jia, D., Lu, M., Ben-Jacob, E., Onuchic, J.N., and Levine, H. (2015). Implications of the Hybrid Epithelial\/Mesenchymal Phenotype in Metastasis. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00155"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Grosse-Wilde, A., Fouquier d\u2019H\u00e9rou\u00ebl, A., McIntosh, E., Ertaylan, G., Skupin, A., Kuestner, R.E., del Sol, A., Walters, K.A., and Huang, S. (2015). Stemness of the hybrid Epithelial\/Mesenchymal State in Breast Cancer and Its Association with Poor Survival. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126522"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","article-title":"Identification of the tumour transition states occurring during EMT","volume":"556","author":"Pastushenko","year":"2018","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10585-023-10248-0","article-title":"How much do we know about the metastatic process?","volume":"41","author":"Sosa","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","article-title":"Update on Epithelial-Mesenchymal Plasticity in Cancer Progression","volume":"19","author":"Fontana","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e23552","DOI":"10.1002\/dvg.23552","article-title":"Tumor dormancy: EMT beyond invasion and metastasis","volume":"62","author":"Aouad","year":"2024","journal-title":"Genesis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2022.12.002","article-title":"The epigenome and the many facets of cancer drug tolerance","volume":"158","author":"Moore","year":"2023","journal-title":"Adv. Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"27067","DOI":"10.18632\/oncotarget.8166","article-title":"Stability of the hybrid epithelial\/mesenchymal phenotype","volume":"7","author":"Jolly","year":"2016","journal-title":"Oncotarget"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-14-2535","article-title":"Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival","volume":"75","author":"Schliekelman","year":"2015","journal-title":"Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"15436","DOI":"10.18632\/oncotarget.3623","article-title":"OVOL guides the epithelial-hybrid-mesenchymal transition","volume":"6","author":"Jia","year":"2015","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Genna, A., Vanwynsberghe, A.M., Villard, A.V., Pottier, C., Ancel, J., Polette, M., and Gilles, C. (2020). EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers, 12.","DOI":"10.3390\/cancers12061632"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"025002","DOI":"10.1088\/1478-3975\/aaf8d4","article-title":"Testing the gene expression classification of the EMT spectrum","volume":"16","author":"Jia","year":"2019","journal-title":"Phys. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"106964","DOI":"10.1016\/j.isci.2023.106964","article-title":"Population dynamics of EMT elucidates the timing and distribution of phenotypic intra-tumoral heterogeneity","volume":"26","author":"Najafi","year":"2023","journal-title":"iScience"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Sinha, D., Saha, P., Samanta, A., and Bishayee, A. (2020). Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression. Biomolecules, 10.","DOI":"10.3390\/biom10111561"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-21-4370","article-title":"Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion","volume":"82","author":"Mullins","year":"2022","journal-title":"Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13058-024-01888-5","article-title":"Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma","volume":"26","author":"Lien","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Kanai, R., Norton, E., Stern, P., Hynes, R.O., and Lamar, J.M. (2024). Identification of a Gene Signature That Predicts Dependence upon YAP\/TAZ-TEAD. Cancers, 16.","DOI":"10.3390\/cancers16050852"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10120-023-01462-6","article-title":"Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer","volume":"27","author":"Zaafour","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0681","article-title":"A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models","volume":"23","author":"Hillen","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41467-024-46048-7","article-title":"Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100916","DOI":"10.1016\/j.xgen.2025.100916","article-title":"CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST","volume":"5","author":"Liu","year":"2025","journal-title":"Cell Genom."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13046-025-03402-x","article-title":"Epithelial-to-mesenchymal transition drives cancer genomic instability","volume":"44","author":"Carstens","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1158\/0008-5472.CAN-25-1443","article-title":"To EMT or Not to EMT: Ablation of Mesenchymal Tumor Cell Lineages Reveals the Essential Role of EMT in Pancreatic Cancer Initiation and Evolution","volume":"85","author":"Peura","year":"2025","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"112720","DOI":"10.1016\/j.isci.2025.112720","article-title":"Recent advances in bladder cancer stem cells (BCSCs): A descriptive review of emerging therapeutic targets","volume":"28","author":"Li","year":"2025","journal-title":"iScience"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-025-02133-x","article-title":"Precise targeting of transcriptional co-activators YAP\/TAZ annihilates chemoresistant brCSCs by alteration of their mitochondrial homeostasis","volume":"10","author":"Talukdar","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11684-024-1107-1","article-title":"Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: Distinct and concerted control","volume":"19","author":"Huang","year":"2025","journal-title":"Front. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1038\/s41598-024-54808-0","article-title":"VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma","volume":"14","author":"Rodrigo","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-025-02289-8","article-title":"Double-sided niche regulation in skin stem cell and cancer: Mechanisms and clinical applications","volume":"24","author":"Pham","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"107642","DOI":"10.1016\/j.jbc.2024.107642","article-title":"SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions","volume":"300","author":"Gonzalez","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1038\/s41467-024-54997-2","article-title":"Cell competition drives bronchiolization and pulmonary fibrosis","volume":"15","author":"Warren","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Sab\u0103u, A.H., Tinca, A.C., Niculescu, R., Cocuz, I.G., Cozac-Sz\u00f6ke, A.R., Lazar, B.A., Chiorean, D.M., Budin, C.E., and Cotoi, O.S. (2025). Cancer Stem Cells in Melanoma: Drivers of Tumor Plasticity and Emerging Therapeutic Strategies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157419"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.molmed.2025.03.010","article-title":"Acquired resistance to immunotherapy in solid tumors","volume":"31","author":"Verdys","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12964-024-01711-w","article-title":"Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"150066","DOI":"10.1016\/j.bbrc.2024.150066","article-title":"CD47-mediated immune evasion in early-stage lung cancer progression","volume":"720","author":"Chuang","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Matsuida, H., Mimura, K., Nakajima, S., Saito, K., Hayashishita, S., Takiguchi, C., Nirei, A., Kikuchi, T., Hanayama, H., and Okayama, H. (2025). Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer. Cells, 14.","DOI":"10.3390\/cells14151212"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Chariou, P.L., Minnar, C.M., Tandon, M., Guest, M.R., Chari, R., Schlom, J., and Gameiro, S.R. (2024). Generation of murine tumor models refractory to \u03b1PD-1\/-L1 therapies due to defects in antigen processing\/presentation or IFN\u03b3 signaling using CRISPR\/Cas9. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0287733"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e70047","DOI":"10.1111\/sji.70047","article-title":"Essential Role of NLRC5 in Cancer Immune Surveillance and Cancer Immunoediting","volume":"102","author":"Shukla","year":"2025","journal-title":"Scand. J. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"eadl2171","DOI":"10.1126\/sciimmunol.adl2171","article-title":"The tumor-intrinsic role of the m(6)A reader YTHDF2 in regulating immune evasion","volume":"9","author":"Xiao","year":"2024","journal-title":"Sci. Immunol."},{"key":"ref_122","first-page":"121","article-title":"Upregulation of MHC I Antigen Processing Machinery Gene Expression in Breast Cancer Cells by Trichostatin A","volume":"58","author":"Murtadha","year":"2024","journal-title":"Mol. Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41416-024-02698-4","article-title":"Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer","volume":"131","author":"Jeong","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Yu, X., and Xu, J. (2024). TWIST1 Drives Cytotoxic CD8+ T-Cell Exhaustion through Transcriptional Activation of CD274 (PD-L1) Expression in Breast Cancer Cells. Cancers, 16.","DOI":"10.3390\/cancers16111973"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: Challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: Updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/2326-6066.CIR-22-0326","article-title":"Coexisting Alterations of MHC Class I Antigen Presentation and IFN\u03b3 Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy","volume":"10","author":"Nielsen","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-cancerbio-070220-111016","article-title":"Central Role of the Antigen-Presentation and Interferon-\u03b3 Pathways in Resistance to Immune Checkpoint Blockade","volume":"6","author":"Paschen","year":"2022","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41577-025-01208-8","article-title":"Defects in antigen processing and presentation: Mechanisms, immune evasion and implications for cancer vaccine development","volume":"26","author":"Huber","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"115445","DOI":"10.1016\/j.celrep.2025.115445","article-title":"AGO2 mediates immunotherapy failure via suppressing tumor IFN-gamma response-dependent CD8(+) T cell immunity","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"eabb0152","DOI":"10.1126\/scitranslmed.abb0152","article-title":"Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma","volume":"12","author":"Kalbasi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e012096","DOI":"10.1136\/jitc-2025-012096","article-title":"Basic rules to respond to PD-1 blockade cancer immunotherapy","volume":"13","author":"Ribas","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-025-02294-x","article-title":"Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors","volume":"24","author":"Wawrzyniak","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e2502597122","DOI":"10.1073\/pnas.2502597122","article-title":"Tumor immune evasion: Systemic immunosuppressive networks beyond the local microenvironment","volume":"122","author":"Yan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12032-025-02703-7","article-title":"Function of antigen-presenting cells in non-small-cell lung cancer (NSCLC)","volume":"42","author":"Kumar","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.trecan.2024.09.008","article-title":"Time to heal: Inhibiting fibrosis prevents glioblastoma recurrence","volume":"10","author":"Mundhe","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/1541-7786.MCR-25-0251","article-title":"Myeloid-Derived Suppressor Cells: Orchestrators of Tumor Immune Evasion and Therapeutic Vulnerabilities","volume":"23","author":"Wang","year":"2025","journal-title":"Mol. Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"101087","DOI":"10.1016\/j.jhepr.2024.101087","article-title":"PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-024-45595-3","article-title":"Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway","volume":"15","author":"Licaj","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","article-title":"Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer","volume":"15","author":"Croizer","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.7150\/thno.90627","article-title":"Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-\u03b2 activity and CD8(+) T-cell infiltration in breast cancer","volume":"14","author":"Honda","year":"2024","journal-title":"Theranostics"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"467","DOI":"10.62347\/NJRZ3602","article-title":"A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers","volume":"14","author":"Sulaiman","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s42003-025-08585-9","article-title":"The role of environmentally mediated drug resistance in facilitating the spatial distribution of residual disease","volume":"8","author":"Milne","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"189137","DOI":"10.1016\/j.bbcan.2024.189137","article-title":"The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions","volume":"1879","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tem.2023.11.005","article-title":"Metabolic challengers selecting tumor-persistent cells","volume":"35","author":"Mancini","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.freeradbiomed.2025.07.014","article-title":"Modulation of NAD metabolism by oxygen availability","volume":"238","author":"Burtscher","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"102032","DOI":"10.1016\/j.molmet.2024.102032","article-title":"Linking metabolism and histone acetylation dynamics by integrated metabolic flux analysis of Acetyl-CoA and histone acetylation sites","volume":"90","author":"Egger","year":"2024","journal-title":"Mol. Metab."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s13577-024-01046-1","article-title":"Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome","volume":"37","author":"Liu","year":"2024","journal-title":"Hum. Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41418-024-01295-5","article-title":"Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41420-025-02349-4","article-title":"Lactylation in cancer: Metabolic mechanism and therapeutic strategies","volume":"11","author":"Sui","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/BST20230189","article-title":"Complex I activity in hypoxia: Implications for oncometabolism","volume":"52","author":"Chinopoulos","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trecan.2024.10.005","article-title":"Metabolic landscape of disseminated cancer dormancy","volume":"11","author":"Drapela","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Meng, W., Luo, Y., Zhao, L., Zhang, Y., Liu, J., Li, S., Du, Y., and Li, H. (2024). Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1507608"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature14034","article-title":"Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance","volume":"517","author":"Kurtova","year":"2015","journal-title":"Nature"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12964-025-02382-x","article-title":"Endothelial cell-derived apoptotic bodies modulate innate and adaptive immune responses during inflammation","volume":"23","author":"Vella","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Feng, S.R., Dong, E.F., Gao, Z., Xu, M.R., Kwangwari, P., Sun, C.Q., Chen, J.F., Shi, Y.H., Liu, W.R., and Wu, W.X. (2026). Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinoma. Exp. Hematol. Oncol.","DOI":"10.1186\/s40164-026-00792-2"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2581875","DOI":"10.1080\/2162402X.2025.2581875","article-title":"Disruption of CD91 association with AXL and Fgr abrogates HSP-mediated signaling and cancer immunosurveillance","volume":"14","author":"Harkness","year":"2025","journal-title":"Oncoimmunology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"eabm4032","DOI":"10.1126\/sciimmunol.abm4032","article-title":"Pannexin 1 drives efficient epithelial repair after tissue injury","volume":"7","author":"Lucas","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12964-026-02777-4","article-title":"Dying cells as architects of the stem cell niche: A conserved mechanism driving tissue regeneration and tumor therapy resistance","volume":"24","author":"Jiang","year":"2026","journal-title":"Cell Commun. Signal."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"119939","DOI":"10.1016\/j.bbamcr.2025.119939","article-title":"Loss of non-muscle myosin II Zipper leads to apoptosis-induced compensatory proliferation in Drosophila","volume":"1872","author":"Verma","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/imr.13259","article-title":"Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis","volume":"319","author":"Gregory","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1021\/acs.molpharmaceut.4c01314","article-title":"Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis","volume":"22","author":"Feng","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-020-01178-6","article-title":"Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer","volume":"19","author":"Jiang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1801987","DOI":"10.1002\/advs.201801987","article-title":"Redox-Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin-Promoted Cancer Stemness, Metastasis, and Drug Resistance","volume":"6","author":"Liu","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/D3NP00002H","article-title":"Therapeutic vulnerabilities of cancer stem cells and effects of natural products","volume":"40","author":"Reisenauer","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"218000","DOI":"10.1016\/j.canlet.2025.218000","article-title":"Proteomics and single cell profiling identify keratin driven preexisting immunity influences lung squamous carcinoma neoadjuvant therapy","volume":"633","author":"Zhao","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"117450","DOI":"10.1016\/j.celrep.2026.117450","article-title":"Targeting EP2\/EP4-driven expansion of suppressive VSIG4(high) macrophages overcomes immunotherapy resistance in colorectal cancer","volume":"45","author":"Zhang","year":"2026","journal-title":"Cell Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10495-025-02215-9","article-title":"HMGB1 blockade attenuates cardiac injury induced by radiotherapy combined with PD-1 inhibitor while maintaining the anti-tumor efficacy","volume":"31","author":"Liu","year":"2026","journal-title":"Apoptosis"},{"key":"ref_170","first-page":"100310","article-title":"Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice","volume":"3","author":"Saqi","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jso.26673","article-title":"Impact of preoperative transcatheter rectal arterial chemoembolization with concurrent chemoradiotherapy on surgery and prognosis of patients with locally advanced rectal cancer","volume":"124","author":"Meng","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e70456","DOI":"10.1002\/mco2.70456","article-title":"Intra-arterial Delivery of Tislelizumab plus Transarterial Chemoembolization for Rectal Cancer: A Novel Regimen to Achieve Sphincter Preservation and Prevent Anastomotic Leakage","volume":"6","author":"Meng","year":"2025","journal-title":"MedComm"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Qiu, G., Tang, Y., Zuo, J., Wu, H., and Wan, Y. (2025). Deciphering spatially confined immune evasion niches in osteosarcoma with 3-D spatial transcriptomics: A literature review. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1640645"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-24-3472","article-title":"Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer","volume":"31","author":"Elliott","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.pan.2024.03.013","article-title":"Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study","volume":"24","author":"Park","year":"2024","journal-title":"Pancreatology"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Meng, W., Pan, L., Huang, L., Li, Q., and Sun, Y. (2024). Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: A review. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1464242"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41588-024-01992-4","article-title":"Spatial biology captures the effects of neoadjuvant chemo-immunotherapy in lung cancer","volume":"57","author":"Chen","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","article-title":"Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics","volume":"26","author":"Gulati","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","article-title":"Programs, origins and immunomodulatory functions of myeloid cells in glioma","volume":"640","author":"Miller","year":"2025","journal-title":"Nature"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41592-025-02737-9","article-title":"Benchmarking single-cell multi-modal data integrations","volume":"22","author":"Fu","year":"2025","journal-title":"Nat. Methods"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.cels.2024.12.002","article-title":"Multiome Perturb-seq unlocks scalable discovery of integrated perturbation effects on the transcriptome and epigenome","volume":"16","author":"Metzner","year":"2025","journal-title":"Cell Syst."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e012066","DOI":"10.1136\/jitc-2025-012066","article-title":"Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception","volume":"13","author":"Chen","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-024-00828-8","article-title":"Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease","volume":"5","author":"Lemaitre","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/1759-7714.15281","article-title":"Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments","volume":"15","author":"Oh","year":"2024","journal-title":"Thorac. Cancer"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s43018-025-00960-z","article-title":"Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer","volume":"6","author":"Henriksen","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Ferreira, N., Alves, F., and Markus, A. (2025). Organoid-Immune Cell Co-culture for Stable Live Imaging. Methods in Molecular Biology, Springer.","DOI":"10.1007\/7651_2025_627"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"bbae151","DOI":"10.1093\/bib\/bbae151","article-title":"The HLA-I landscape confers prognosis and antitumor immunity in breast cancer","volume":"25","author":"Ding","year":"2024","journal-title":"Brief. Bioinform."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1038\/s44318-024-00206-1","article-title":"Targeting SWI\/SNF ATPases reduces neuroblastoma cell plasticity","volume":"43","author":"Xu","year":"2024","journal-title":"Embo J."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1038\/s41467-023-42417-w","article-title":"DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts","volume":"14","author":"Goyal","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2658916","DOI":"10.1080\/2162402X.2026.2658916","article-title":"Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8(+) T cells","volume":"15","author":"Melief","year":"2026","journal-title":"Oncoimmunology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","article-title":"LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade","volume":"174","author":"Sheng","year":"2018","journal-title":"Cell"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e2025840118","DOI":"10.1073\/pnas.2025840118","article-title":"Activation of NF-\u03baB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","article-title":"Activation of lysosomal iron triggers ferroptosis in cancer","volume":"642","author":"Baron","year":"2025","journal-title":"Nature"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"108421","DOI":"10.1016\/j.celrep.2020.108421","article-title":"Melanoma Persister Cells Are Tolerant to BRAF\/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation","volume":"33","author":"Shen","year":"2020","journal-title":"Cell Rep."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1158\/1078-0432.CCR-19-0253","article-title":"A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors","volume":"25","author":"Aloia","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e06950","DOI":"10.1002\/advs.202506950","article-title":"EGFR-TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Meng, W., Liu, Y., Zhang, H., Wang, M., Mu, X., Zhang, Z., and Tie, Y. (2026). Dynamic Time-Resolved Remodeling of the Immune Microenvironment After Resistance to BRAF\/MEK Inhibitors in Melanoma: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27104484"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/cbf.3888","article-title":"Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells","volume":"41","author":"Valipour","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"\u00d3zsv\u00e1ri, B., Magalh\u00e3es, L.G., Latimer, J., Kangasmetsa, J., Sotgia, F., and Lisanti, M.P. (2020). A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01528"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","article-title":"Sublethal cytochrome c release generates drug-tolerant persister cells","volume":"185","author":"Kalkavan","year":"2022","journal-title":"Cell"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1158\/1078-0432.CCR-23-1427","article-title":"A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells","volume":"29","author":"Calvo","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e2401748","DOI":"10.1002\/advs.202401748","article-title":"Overcoming Cancer Persister Cells by Stabilizing the ATF4 Promoter G-quadruplex","volume":"11","author":"Xiao","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Lopez-Gonzalez, J.S., Perez-Medina, M., Galicia-Velasco, M., and Aguilar-Cazares, D. (2026). Drug-tolerant persister cells in cancer: A scoping review of definitions, models, and molecular mechanisms. Front. Oncol., 16.","DOI":"10.3389\/fonc.2026.1771061"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1158\/0008-5472.CAN-13-0110","article-title":"ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status","volume":"73","author":"Huntoon","year":"2013","journal-title":"Cancer Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/onc.2011.358","article-title":"Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells","volume":"31","author":"Ferrao","year":"2012","journal-title":"Oncogene"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41418-025-01656-8","article-title":"Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms","volume":"33","author":"Davern","year":"2025","journal-title":"Cell Death Differ."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41420-025-02375-2","article-title":"BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism","volume":"11","author":"Saxena","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.annonc.2024.03.003","article-title":"Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: Does it help tailor adjuvant treatment?","volume":"35","author":"Agostinetto","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11912-024-01501-0","article-title":"Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?","volume":"26","author":"Schlam","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ijc.34867","article-title":"Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass","volume":"154","author":"Stillger","year":"2024","journal-title":"Int. J. Cancer"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.trecan.2024.04.004","article-title":"Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer","volume":"10","author":"Abbosh","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: From cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.annonc.2023.11.009","article-title":"Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer-evaluation in a nationwide Danish cohort","volume":"35","author":"Henriksen","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Tan, A.C., Liao, B.C., Li, M., Lee, D., Uehara, Y., Thamlikitkul, L., Zhang, J.T., Zheng, M., Lee, C.K., and Pavlakis, N. (2026). Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group. J. Thorac. Oncol.","DOI":"10.1200\/JCO.2026.44.19_suppl.289"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1111\/cas.14926","article-title":"CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer","volume":"112","author":"Taniguchi","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ccell.2025.07.008","article-title":"Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications","volume":"43","author":"Dai","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2025.03.005","article-title":"Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit","volume":"43","author":"Pauken","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1038\/s41467-024-52977-0","article-title":"Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Wang, H., Sun, H., Yi, S., Jin, Y., Lu, Y., Zuo, R., Yang, Y., Dong, Z., Guo, Y., and Pan, Z. (2026). Residual disease subtyping predicts survival and guides adjuvant immunotherapy in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1742272"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"e005160","DOI":"10.1136\/jitc-2022-005160","article-title":"Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: A pooled analysis","volume":"10","author":"Zhai","year":"2022","journal-title":"J. Immunother. Cancer"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/1065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:35:46Z","timestamp":1784648146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/1065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":228,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biom16071065"],"URL":"https:\/\/doi.org\/10.3390\/biom16071065","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}